Skip to content

Abeona Therapeutics Inc.

ABEO· NasdaqCore metricsCIK 318306

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.22%
Market cap
$130.58M
57.15M shares
Filings
1,035
$13.49M
Q3 2026+66.3% FY25 yoy
-$4.81M
Q3 2026N/M FY25 yoy
-$13.00M
Q3 2026N/M FY25 yoy
-$47.24M
Q3 2026derivedN/M FY25 yoy
-$0.08
Q3 2026N/M FY25 yoy
$66.28M
Q3 2026+235.8% FY25 yoy
$130.58M
—
3.3×
1.0×
-50.81%
—

Twelve months to Sep 30, 2026 · derived

Price

$2.2945.20%$1.88past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.82MFY 2025
$10.00M0FY 2012FY 2017FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$5,820,000reported
FY 20232023-12-31$3,500,000reported
FY 20222022-12-31$1,414,000reported
FY 20212021-12-31$3,000,000reported
FY 20202020-12-31$10,000,000reported
FY 20182018-12-31$2,998,000reported
FY 20172017-12-31$837,000reported
FY 20162016-12-31$889,000reported
FY 20152015-12-31$1,040,000reported
FY 20142014-12-31$925,000reported
FY 20132013-12-31$2,042,000reported
FY 20122012-12-31$4,404,000reported

Segments

Products
Revenue by Products, FY2020 to FY2025FY2020License and Other Revenues · FY2020 · $10.00MFY2021License and Other Revenues · FY2021 · $3.00MFY2025License · FY2025 · $3.40MProduct · FY2025 · $2.42M
LineFY2025ShareChange
License$3.40M58%—
Product$2.42M42%—
License and Other Revenues———
Total$5.82M

From the 10-K filed Mar 17, 2026ABEO

Pharmaceutical preparations

Abeona Therapeutics Inc. is the 186th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR